Sight Sciences (SGHT) Preferred Stock Liabilities (2020 - 2021)
Sight Sciences' (SGHT) quarterly Preferred Stock Liabilities came in at $117.3 million in Q2 2021, little changed quarter-over-quarter from $117.3 million in Q1 2021.
Sight Sciences (SGHT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Sight Sciences' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $117.3 million for Q2 2021.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $117.3 million in Q2 2021; TTM through Jun 2021 was $117.3 million, a N/A change from a year earlier, with the FY2020 full-year figure at $117.3 million, changed N/A from the prior year.
- Preferred Stock Liabilities was little changed at $117.3 million in Q2 2021 per SGHT's latest filing, from $117.3 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $117.3 million in Q4 2020 and bottomed at $94.2 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 117.33 Mn |
| Mar 31, 2021 | 117.33 Mn |
| Dec 31, 2020 | 117.33 Mn |
| Sep 30, 2020 | 94.24 Mn |